Cannabis Use and Trajectories of Depression and Stress Across the Prenatal Period.  Constantino-Pettit A, Tillman R, Wilson J, Lashley-Simms N, Vatan N, Atkinson A, Leverett SD, Lenze S, Smyser CD, Bogdan R, Rogers C, Agrawal A.  JAMA ...

Risk thresholds for the frequency of cannabis use during pregnancy and adverse neonatal outcomes: protocol for a systematic review and dose-response meta-analysis.  Robinson T, Fischer B, Hautala R, Bertram M, Ali MU, Farrokhyar F, Jack S, K...

Use of cannabis to manage symptoms of mental and physical health conditions during pregnancy: analysis of a pro-cannabis pregnancy forum.  Gunn RL, Aston ER, Artis L, Nesi J, Pedersen ER, Micalizzi L.  Front Psychiatry. 2024 Dec 10;15:...

Association between buprenorphine dose and outcomes among pregnant persons with opioid use disorder Jarlenski, Marian et al. American Journal of Obstetrics & Gynecology, Volume 0, Issue 0  Abstract https://www.ajog.org/article/S0002-9...

Physiologically based pharmacokinetic modeling of long-acting extended-release naltrexone in pregnant women with opioid use disorder.  Shenkoya B, Gopalakrishnan M, Eke AC.  CPT Pharmacometrics Syst Pharmacol. 2024 Nov;13(11):1939-1952...

Maternal exposure to buprenorphine, but not methadone, during pregnancy reduces social play behavior across two generations of offspring.  Nyberg H, Bogen IL, Nygaard E, Achterberg M, Andersen JM.  Psychopharmacology (Berl). 2024 Dec 5...